Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsThe history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.
US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.
Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.
Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.
A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.
Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.
1.
Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction
2.
According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.
3.
In a study, immune detection of oral cancers is linked to obesity.
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
FDA approves Blenrep for relapsed or refractory multiple myeloma
1.
The Benefits and Risks of Cervical Conization
2.
Know About Lymphangioma: Symptoms, Causes, and Treatments
3.
Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars
4.
A New Dawn for Triple-Negative Breast Cancer: Emerging Therapies and the Art of Healing
5.
Ferroptosis-Modulating Therapies for Treatment-Resistant Malignancies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
2.
Future of Hematology
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
4.
Diagnosis and Management in Hematology
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge